107 related articles for article (PubMed ID: 3510917)
1. A model for testing compounds influencing porphyrin synthesis.
Kotal P; Jirsa M; Kordac V
Int J Biochem; 1986; 18(1):57-61. PubMed ID: 3510917
[TBL] [Abstract][Full Text] [Related]
2. [A new model for testing substances affecting the synthesis of heme].
Kotal P; Jirsa M; Kaláb M; Cervinka J; Martásek P; Kordac V
Sb Lek; 1989 Apr; 91(4):113-22. PubMed ID: 2662380
[TBL] [Abstract][Full Text] [Related]
3. [Experimental study of the action of antimalarial agents with respect to therapy in porphyria. Combined effect of chloroquine and pyrimethamine].
Kotal P; Jirsa M; Kaláb M; Kordac V
Cas Lek Cesk; 1989 Jan; 128(3):87-9. PubMed ID: 2655915
[TBL] [Abstract][Full Text] [Related]
4. The influence of chloroquine on the formation of porphyrins by yeasts.
Kotal P; Vernerová J; Jirsa M; Kordac V
Int J Biochem; 1984; 16(10):1087-90. PubMed ID: 6394404
[TBL] [Abstract][Full Text] [Related]
5. Effects of chloroquine in hematoporphyrin-treated animals.
Egger NG; Goeger DE; Anderson KE
Chem Biol Interact; 1996 Oct; 102(2):69-78. PubMed ID: 8950222
[TBL] [Abstract][Full Text] [Related]
6. Effect of chloroquine on membrane permeability in yeast--release of cellular coproporphyrin.
Kotal P; Kotyk A; Jirsa M; Kordac V
Int J Biochem; 1988; 20(5):539-42. PubMed ID: 3286314
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of porphyria cutanea tarda with intermittent chloroquine].
Raff M; Formanek I
Hautarzt; 1980 Aug; 31(8):437-40. PubMed ID: 7451150
[TBL] [Abstract][Full Text] [Related]
8. Effect of chloroquine wash-out period of photosensitizers in the skin and selected organs in rats.
Zima T; Jirsa M; Jirsa M; Jirásková M; Bradová V; Stádník B
Physiol Res; 2004; 53(1):103-8. PubMed ID: 14984321
[TBL] [Abstract][Full Text] [Related]
9. Effects of new anticonvulsant medications on porphyrin synthesis in cultured liver cells: potential implications for patients with acute porphyria.
Hahn M; Gildemeister OS; Krauss GL; Pepe JA; Lambrecht RW; Donohue S; Bonkovsky HL
Neurology; 1997 Jul; 49(1):97-106. PubMed ID: 9222176
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 induction, uroporphyrinogen decarboxylase depression, porphyrin accumulation and excretion, and gender influence in a 3-week rat model of porphyria cutanea tarda.
Franklin MR; Phillips JD; Kushner JP
Toxicol Appl Pharmacol; 1997 Dec; 147(2):289-99. PubMed ID: 9439724
[TBL] [Abstract][Full Text] [Related]
11. Familial porphyria cutanea tarda: the pattern of porphyrins formed from porphobilinogen by hemolysates.
Alleman MA; Wilson JH; van den Berg JW; Edixhoven-Bosdijk A; van Gastel-Quist LM
Clin Chem; 1982 May; 28(5):1144-7. PubMed ID: 7074894
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of porphyria cutanea tarda symptomatica from other types of porphyria by measurement of isocoproporphyrin in faeces.
Elder GH
J Clin Pathol; 1975 Aug; 28(8):601-7. PubMed ID: 1184758
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of new porphyrin metabolites in human porphyria cutanea tarda and in rats treated with hexachlorobenzene by HPTLC, HPLC and liquid secondary ion mass spectrometry.
Luo J; Lim CK
Biomed Chromatogr; 1995; 9(3):113-22. PubMed ID: 7655298
[TBL] [Abstract][Full Text] [Related]
14. [Results of treatment of porphyria cutanea tarda with bloodletting and chloroquine].
Seubert S; Seubert A; Stella AM; Guzman H; Batlle A
Z Hautkr; 1990 Mar; 65(3):223-5. PubMed ID: 2339575
[TBL] [Abstract][Full Text] [Related]
15. Studies in porphyria. VI. Biosynthesis of porphyrins in mammalian skin and in the skin of porphyric patients.
Bickers DR; Keogh L; Rifkind AB; Harber LC; Kappas A
J Invest Dermatol; 1977 Jan; 68(1):5-9. PubMed ID: 830770
[TBL] [Abstract][Full Text] [Related]
16. Long-standing changes in the urinary profile of porphyrin isomers after clinical remission of porphyria cutanea tarda.
To-Figueras J; Ozalla D; Mateu CH
Ann Clin Lab Sci; 2003; 33(3):251-6. PubMed ID: 12956438
[TBL] [Abstract][Full Text] [Related]
17. Correlation between levels of free and protein-bound plasma porphyrin and urinary porphyrins in porphyria cutanea tarda.
Moran MJ; Fontanellas A; Santos JL; Enriquez de Salamanca R
Int J Biochem Cell Biol; 1995 Jun; 27(6):585-8. PubMed ID: 7671136
[TBL] [Abstract][Full Text] [Related]
18. Exocytosis as a possible mechanism for the secretion of coproporphyrin from a chloroquine-treated yeast.
Kotal P; Kotyk A
Eur J Pharmacol; 1988 Oct; 155(3):301-3. PubMed ID: 3069482
[TBL] [Abstract][Full Text] [Related]
19. [Inhibition of porphyrin synthesis by isonicotinic acid hydrazide in models simulating porphyria].
Kotal P; Klepácek I; Jirsa M; Kordac V
Sb Lek; 1989 Jun; 91(6):161-8. PubMed ID: 2672290
[TBL] [Abstract][Full Text] [Related]
20. Association between porphyria cutanea tarda and beta-thalassemia major.
Barbieri L; Macrì A; Lupia Palmieri G; Aurizi C; Biolcati G
Cell Mol Biol (Noisy-le-grand); 2009 Jul; 55(2):36-9. PubMed ID: 19656449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
